Category: Prescription Drugs
Global Prescription Drugs
-
Global Endometriosis Treatment Competitive Landscape Professional Research Report 2024
... the uterine lining grows outside the uterus. Treatment strategies for endometriosis can include pain management through medications like nonsteroidal anti-inflammatory drugs (NSAIDs) or hormonal therapies to suppress estrogen production, which can help alleviate symptoms. Surgical ... Read More
-
Global Prescription Delivery Service Competitive Landscape Professional Research Report 2024
... of obtaining necessary medications, this service typically involves patients submitting their prescriptions to a pharmacy through various channels, after which the pharmacy verifies and processes the prescription, packages the medication securely, and coordinates delivery to ... Read More
-
Global Equine Pharmaceuticals and Supplements Competitive Landscape Professional Research Report 2024
... wide range of medications, treatments, and dietary supplements designed to address various equine health concerns and nutritional needs. Equine pharmaceuticals can encompass prescription drugs used to treat illnesses, infections, or injuries in horses, while supplements ... Read More
-
Cytomegalovirus Treatment Market by Diseases (Encephalitis, Gastrointestinal Ulcers, Pneumonia), Drug (Cidofovir, Foscarnet, Ganciclovir), Distribution Channel, Application - Global Forecast 2024-2030
... to reach USD 576.99 million in 2024, at a CAGR 7.67% to reach USD 903.39 million by 2030. The cytomegalovirus (CMV) treatment includes all aspects of medical practices to manage and treat cytomegalovirus infections, a ... Read More
-
Endocrinology Drugs Market by Therapy Area (Diabetes Drugs, Human Growth Hormone, Thyroid Hormone Disorders), Distribution Channel (Hospital pharmacies, Online pharmacies, Retail pharmacies) - Global Forecast 2024-2030
... 32.78 billion in 2023 and expected to reach USD 35.05 billion in 2024, at a CAGR 7.34% to reach USD 53.85 billion by 2030. Endocrinology drugs are medications that are used to treat disorders of ... Read More
-
Dysmenorrhea Treatment Market by Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), Treatment (Medication, Surgery, Therapeutics), Distribution Channel, End-Users - Global Forecast 2024-2030
... to reach USD 7.80 billion in 2024, at a CAGR 8.98% to reach USD 13.09 billion by 2030. Dysmenorrhea treatment refers to the therapeutic approaches for managing and alleviating the pain and discomfort associated with ... Read More
-
Transdermal Patches Market by Product (Matrix, Multi-layer Drug-in-Adhesive, Reservoir), Type (Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Fentanyl Transdermal Patch), Technology, Application, Distribution Channel, End Users - Global Forecast 2024-2030
... estimated at USD 8.57 billion in 2023 and expected to reach USD 9.89 billion in 2024, at a CAGR 16.40% to reach USD 24.84 billion by 2030. Transdermal patches offer a novel therapeutic approach to ... Read More
-
Smoking Cessation & Nicotine De-Addiction Product Market by Product (Drug Therapy, E-Cigarettes, Nicotine Inhalers), Distribution (Drug Store, Hospital Pharmacies, Online Pharmacies) - Global Forecast 2024-2030
... estimated at USD 28.25 billion in 2023 and expected to reach USD 30.89 billion in 2024, at a CAGR 9.65% to reach USD 53.87 billion by 2030. The smoking cessation and nicotine de-addiction market encompasses ... Read More
-
Animal Chewables Market by Composition Type (Botanically Synthesized, Chemically Synthesized), Drug (Analgesics, Anti-Infective, Anti-Ulcers), Mode of Purchase, Distribution Channel, Applications - Global Forecast 2024-2030
... in 2023 and expected to reach USD 151.82 million in 2024, at a CAGR 6.86% to reach USD 226.53 million by 2030. Animal chewables refer to specially formulated edible items designed for animals, primarily pets, ... Read More
-
Familial Adenomatous Polyposis Treatment Market by Type (Aspirin, CEQ-508, Eflornithine Hydrochloride), End-Users (Clinics & Hospitals, Diagnostic Centres, Home Healthcare), Distribution Channel - Global Forecast 2024-2030
... USD 1.12 billion in 2023 and expected to reach USD 1.20 billion in 2024, at a CAGR 7.43% to reach USD 1.85 billion by 2030. Familial Adenomatous Polyposis (FAP) treatment refers to the medical interventions ... Read More
-
Pulmonary Drugs Market by Drug Class (Anti-Cholinergic Agents, Anti-Leukotrienes, Antihistamines), Indication (Allergic Rhinitis, Asthma, Chronic Obstructive Pulmonary Disease), Drug Type, Distribution Channel, End-User - Global Forecast 2024-2030
... USD 79.35 billion in 2023 and expected to reach USD 86.14 billion in 2024, at a CAGR 8.03% to reach USD 136.27 billion by 2030. The pulmonary drugs market encompasses a wide range of therapeutic ... Read More
-
Global Allergic Conjunctivitis Market Report by Disease Type (Seasonal ALLERGIC Conjunctivitis (SAC), Perennial Allergic Conjunctivitis (PAC)), Drug class (Antihistamines & Mast Cell Stabilizers, Corticosteroids, Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies & Drug Stores, Others), Countries and Company Analysis, 2024-2032
... Stores, Others), Countries and Company Analysis, 2024-2032 Allergic Conjunctivitis Market is expected to reach US$ 2.40 Billion by 2032 from US$ 1.96 Billion in 2023, with a CAGR of 2.27% during 2024-2032. Allergic conjunctivitis interchangeably ... Read More
-
Antacids Market - By Drug Class (Proton Pump Inhibitors, Acid Neutralizers, Anti-H. Pyloric Drugs), Indication (Gastroesophageal Reflux Disease, Heartburn, Gastritis), Dosage, Route of Administration, Distribution Channel – Global Forecast (2024 – 2032)
... size will expand at a 5.1% CAGR between 2024 and 2032, attributed to advances in formulation and delivery methods. Innovations such as chewable tablets, fast-dissolving powders, and convenient liquid forms enhance the effectiveness and user ... Read More
-
Global Female Sexual Dysfunction Treatment Market 2024-2028
... the forecast period. Our report on the female sexual dysfunction treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The ... Read More
-
Global Endocrinology Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... 2023 and is forecast to a readjusted size of USD 140400 million by 2030 with a CAGR of 5.0% during review period. Endocrinology drugs are used to treat hormonal problems such as hypothyroidism, diabetes and ... Read More
-
Opioid Market Share, Size, Trends, Industry Analysis Report, By Class (Natural, Semi-synthetic, and fully synthetic); By Release Type; By Product; By Application; By Region; Segment Forecast, 2024 - 2032
... expected to reach USD 26.41 billion by 2032, according to a new study by Polaris Market Research. The report “Opioid Market Share, Size, Trends, Industry Analysis Report, By Class (Natural, Semi-synthetic, and Fully synthetic); By ... Read More
-
E-Prescribing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Solutions (Integrated Solutions, Standalone Solutions), Services (Support, Implementation, Training, Network), By Specialties (Oncology, Sports Medicine, Neurology, Cardiology, Others), By Delivery Mode (Web/Cloud Based, On Premise), By Substances (Controlled Substances, Non-controlled Substances), By Region and Competition, 2019-2029F
... (Web/Cloud Based, On Premise), By Substances (Controlled Substances, Non-controlled Substances), By Region and Competition, 2019-2029F Global E-Prescribing Market was valued at USD 2.52 Billion in 2023 and is anticipated to project steady growth in the ... Read More
-
Global Atopic Dermatitis Drugs Market 2024-2028
... period. Our report on the atopic dermatitis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Global Gastroesophageal Reflux Disease (Gerd) Market 2024-2028
... the forecast period. Our report on the gastroesophageal reflux disease (GERD) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The ... Read More
-
Global Paracetamol Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
Global Barbiturate Drug Market 2024-2031
... Applications) Forecast Period (2024-2031) Barbiturate drug market is anticipated to grow at a moderate CAGR of 3.5% during the forecast period (2024-2031). Barbiturates are a class of depressant drugs that are chemically derived from barbituric ... Read More
-
Anorexiants Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Route of Administration (Subcutaneous Anorexiants, Oral Anorexiants), By Distribution Channels (Online Pharmacy, Retail Pharmacy, And Hospital Pharmacy), By Region and Competition, 2019-2029F
... Anorexiants Market was valued at USD 924.67 million in 2023 and is anticipated tproject steady growth in the forecast period with a CAGR of 4.84% through 2029. The Global Anorexiants Market constitutes a dynamic segment ... Read More
-
House Dust Mite Allergy Global Market Opportunities And Strategies To 2033
... Specific Immunoglobulin E (IGE) Blood TestCovering: Sanofi SA; Teva Pharmaceutical Industries LTd; Bayer AG; Johnson and Johnson; Merck & Co. Inc. House Dust Mite Allergy Global Market Opportunities And Strategies To 2033 from The Business ... Read More
-
Vitiligo Treatment Global Market Opportunities And Strategies To 2033
... Treatment Options5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Incyte Corporation; Dr. Reddy’s Laboratories Ltd; Glenmark Pharmaceuticals Ltd; Strides Pharma Science Limited; Issar Pharmaceuticals Pvt Vitiligo Treatment Global Market Opportunities And Strategies To ... Read More
-
Neurodegenerative Drugs
... at a CAGR of 4.2% over the analysis period 2023-2030. Multiple Sclerosis Drugs, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$38.3 Billion by the end ... Read More
Research Assistance
